If your information is coming from the City of Hope, like if youre a cancer patient, if its coming from the Mayo Clinic, or Sloan Kettering, those are trusted sources
At 1 year, you can see clearly there was a significant weight loss with both semaglutide and tirzepatide treatment, and a significant improvement in HbA1c, Satish K
Mast Cell Genotype Report: Access this content: An active subscription is required to access this content
As of 2026, no registered Phase I or Phase II trials for KPV in humans are listed on ClinicalTrials.gov.12 The FDA specifically cited the lack of human exposure data as part of its 2023 categorization decision.8 What this means practically: Efficacy signals from animal models do not automatically translate to human outcomes Long-term safety in human populations has not been established Dosing protocols remain clinical judgment calls rather than evidence-based standards Any patient considering KPV should do so under clinical supervision with baseline inflammatory marker testing These limitations do not invalidate the research
Works well for those with more fat distribution there
Some research protocols have successfully minimized injection site reactions by warming the solution to room heat before use and ensuring slow, steady injection technique
